|BMO Capital Markets Corp.||Do Kim||212-885-4091|
|Cowen and Co., LLC||Eric Schmidt||646-562-1345|
|Evercore ISI||Josh Schimmer||212-497-0856|
|* Goldman, Sachs & Co.||Salveen Richter||212-934-4204|
|Janney Montgomery Scott LLC||Debjit Chattopadhyay||215-665-6224|
|Jefferies & Company||Eun Yang||212-284-2264|
|J.P. Morgan Securities Inc.||Jessica Fye||212-622-4165|
|Laidlaw & Company||Yale Jen||212-953-4978|
|Leerink Swann & Company||Paul Matteis||617- 918-4585|
|Morgan Stanley & Co. LLC||David Lebowitz||212-761-0324|
|Needham & Company, LLC||Chad Messer||212-705-0317|
|Sanford C. Bernstein & Co., LLC||Vincent Chen||212-969-6607|
|Stifel Nicolaus||Stephen Willey||212-271-3620|
|Wells Fargo Securities, LLC||James Birchenough||415-947-5470|
* Coverage suspended while analyst is on maternity leave.
Ionis Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ionis Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Ionis Pharmaceuticals or its management. Ionis Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.